Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Cancers|April 30, 2021
Find the Flame: Predictive Biomarkers for Immunotherapy in MelanomaMattia Garutti, Serena Bonin, Silvia Buriolla, et al.
Biochemical and Biophysical Research Communications|June 21, 2012
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancersMattia Poletto, Carla Di Loreto, Daniela Marasco, et al.
Critical Reviews in Oncology/Hematology|April 8, 2006
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm)Gilberto de Castro Junior, Fabio Puglisi, Evandro de Azambuja, et al.
Expert Opinion on Drug Safety|December 5, 2022
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effectsPaola Di Nardo, Camilla Lisanti, Mattia Garutti, et al.
Clinical Breast Cancer|December 11, 2012
Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?Marta Bonotto, Claudia Bozza, Carla Di Loreto, et al.
Cancers|July 2, 2021
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future PerspectivesAlessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, et al.
Breast (Edinburgh, Scotland)|December 21, 2024
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancerBrenno Pastò, Riccardo Vida, Arianna Dri, et al.
The Oncologist|November 7, 2023
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 TrialLorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, et al.
The Journal of Dermatology|May 18, 2021
Tips for difficult to diagnose hypomelanotic melanomas on reflectance confocal microscopyMaria Antonietta Pizzichetta, Vincenzo Canzonieri, Pietro Rubegni, et al.
Future Oncology (London, England)|March 23, 2017
Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'Vito Lorusso, Saverio Cinieri, Agnese Latorre, et al.
Pageof 31